This guideline, developed by the British Society of Gastroenterology (BSG) and the Association of Coloproctology of Great Britain and Ireland (ACPGBI), provides a comprehensive strategy for the use of faecal immunochemical testing (FIT) in patients presenting with signs or symptoms suggestive of colorectal cancer (CRC).

Backed by a systematic review of over 13,000 publications and expert consensus, the guideline outlines evidence-based recommendations to support clinical decision-making in primary care, aiming to improve diagnostic accuracy, prioritize investigations, and enhance patient outcomes.